HORDOMAS are rare, slow-growing malignant tumors of the midline, representing approximately 1% of all malignant tumors of the bone and 0.1 to 0.2% of intracranial neoplasms. 10, 20 They are thought to arise from cell rests, particularly of the proximal and distal extremes of the notochord. Approximately 50% develop in the sacrococcygeal region, 35% in the sphenooccipital region, and 15% in vertebrae. 48 Most chordomas involving the sellar region are parasellar or suprasellar, and largely or entirely intrasellar lesions are very rare. 31, 38 In terms of their imaging characteristics and clinical presentation, intrasellar chordomas may mimic pituitary adenomas.
and invasion of the sphenoid bone. A high-resolution CT scan revealed a large, partly calcified intrasellar tumor showing suprasellar extension and erosion of the sphenoid bone. An MR imaging study demonstrated that the lesion measured 3.6 cm in its greatest diameter and that it elevated and stretched the optic chiasm, infiltrated the left cavernous sinus, and protruded into the sphenoid sinus ( Fig. 1) . No endocrinopathy was noted, and serum pituitary hormone levels were normal. Initially, the lesion was considered to be a nonfunctioning pituitary adenoma (Grade IVB according to the Hardy classification 16 ). During transsphenoidal surgery, intrasellar and suprasellar portions of the tumor were resected, the optic chiasm was decompressed, and the intracavernous part of the lesion was subtotally removed. A small portion of the tumor remained attached to the left carotid artery. The patient underwent conventional fractionated radiotherapy, receiving a total dose of 6000 cGy. At the 4-year follow-up he was asymptomatic.
Pathological Findings. The multiple tan-to-red tumor fragments were composed of large epithelioid and physaliphorous cells arranged in lobules and embedded in a mucoid stroma. The nuclei were round and uniform with no mitotic figures (Fig. 2) . Examination of the specimen by using the periodic-acid-Schiff method demonstrated abundant cytoplasmic glycogen. Fragments of adenohypophyseal parenchyma adjacent to chordoma elements appeared to be histologically normal. Immunocytochemical analysis of the chordoma cells showed focal positivity for EMA, S-100 protein, ␣1-FP, and vimentin. In addition, the cells were immunoreactive for pan-keratin but negative for immunoreactivity for the HMW keratins 1, 5, 10, and 14 ( Fig. 3) . Scant immunoreactivity for CEA was also noted, whereas NSE stains were negative for immunoreactivity. Ultrastructurally, the tumor was composed of large cells containing irregular nuclei with multiple indentations and prominent nucleoli. The cytoplasm contained scattered profiles of rough endoplasmic reticulum, occasional mitochondria, beta particles of glycogen intermediate filaments, and vacuoles. Cytoplasmic vacuoles were smaller than those in the intercellular matrix. Analysis of DNA revealed a diploid histogram.
Case 2
This 80-year-old woman was admitted with a 1-month history of right ptosis, which had been followed within days by ipsilateral orbital pain. Her medical history was noncontributory. A CT scan revealed a contrast-enhancing intrasellar mass that was eroding the sellar floor and a small portion of the clivus. In addition, MR imaging demonstrated that the mass measured 2.5 cm in diameter and that it occupied the pituitary fossa, invaded the right cavernous sinus, and protruded into the sphenoid sinus (Figs. 4 and 5). Its upward growth elevated the pituitary gland and the optic chiasm. Moderate tumoral contrast enhancement was noted, mainly at its periphery. Despite a slightly elevated basal prolactin level (36 ng/ml; normal range 5-20 ng/ml), the endocrine assessment demonstrated normal findings. On opening the dura at transsphenoidal surgery, the tumor was seen to protrude into the sphenoid sinus. The rather hard and moderately hemorrhagic tumor was partially removed.
Pathological Findings. Microscopically, the tumor was composed of lobules of large cells with uniform nuclei, mostly embedded in a chondroid stroma. Small numbers of vacuolated (physaliphorous) cells were arranged in a syncytial manner (Fig. 6 ). In addition, lobules of tumor cells were occasionally separated by bundles of fibrous tissue. The tumor cells contained abundant glycogen. Immunostains were positive for EMA, S-100 protein, vimentin, and for cytokeratins 5, 8, 18 , and 19. The CEA preparations showed only mild focal immunoreactivity.
Case 3
This 63-year-old woman was referred to the Mayo Clinic for resection of an incidentally discovered sellar mass. While undergoing chemotherapy for local recurrence of a previously resected ovarian carcinoma, she was noted to have developed a right scotoma. Ophthalmological evaluation demonstrated a right-sided pupillary defect, and visual field examination revealed an ipsilateral asymmetric bitemporal hemianopsia. On subsequent radiological evaluation, a large asymmetric intrasellar mass was seen to be eroding the right anterior clinoid artery. A CT scan revealed suprasellar extension on the right side. sellar floor and clivus appeared normal. Basal serum prolactin levels were elevated at 97.5 ng/ml, whereas folliclestimulating hormone and luteinizing hormone levels were low at 15.2 mIU/ml and 3.3 mIU/ml, respectively (normal range 20-138 mIU/ml and 15-62 mIU/ml, respectively). Both clinical and neuroimaging findings suggested a nonsecreting pituitary adenoma with chiasmal compression (Hardy Grade IIIB). 16 During transsphenoidal surgery, the sphenoid bone was destroyed, the sinus itself being filled with a multinodular tumor of rubbery consistency. The lesion had greatly expanded the dura. The entire tumor, both intrasellar and intracranial, was removed. The postoperative course was uneventful, with significant improvement of right-sided vision. Four months later, the patient died of the underlying ovarian cancer. No autopsy was performed.
Pathological Findings. On light microscopic examination, the tumor was shown to be composed primarily of physaliphorous cells forming sheets that were separated by broad fibrous bands. Focal hemorrhage and hemosiderin deposits were observed (Fig. 7) . One tissue fragment showed bone invasion.
Sources of Supplies and Equipment
The Elite Vectastain kit (Vector Laboratories, Inc., Burlingame, CA) was used in the cytochemical analysis. We 
Discussion
The genesis of chordomas has been linked to notochordal rests, which are found embedded in the dorsum sellae in 4 to 5% of autopsies conducted in adults. 51 Despite initial skepticism, 40 many researchers now believe that such rests appear to represent sites at which sellar chordomas develop. Similarities in immunohistochemical, ultrastructural, and in vitro features between chordoma and noto- chordal elements provide support for the notochordal theory. 6 To date, only one case has been reported in which there was an entirely intrasellar chordoma unassociated with sphenoid bone involvement. 31 The incidence of endocranial chordomas shows a slight male predilection (6:5), 50 whereas chordomas occurring at other sites exhibit a 2:1 male/female ratio. 19 The incidence of skull base chordomas is also higher in younger patients, often appearing in the second to fifth decades of life. 17, 19, 20 Based on anatomical location and clinical features, 14 chordomas of the skull base can be classified into three categories: 1) sellar chordomas associated with chiasmal compression and hypopituitarism; 2) parasellar tumors characterized by oculomotor nerve palsy, optic tract compression, and hypopituitarism; and 3) tumors involving the clival region and presenting with bilateral sixth cranial nerve paresis and brainstem compression. Accordingly, our three patients are classified as having chordoma defined in the first classification.
As previously stated, chordomas involving the sellar region are uncommon. Including our three cases, only 21 tumors with a primarily intrasellar component have been reported since 1966 (Table 1) . 2, 4, 7, 9, 12, 14, 22, 23, 31, 32, [36] [37] [38] 46, 47 No tumor predilection for either sex was noted, and patients' ages were within the expected range. Fifteen patients experienced visual deficits (71.4%). In nine cases (43%) a pituitary adenoma was suspected.
The neuroimaging presentation of Falconer Type 1 and 2 lesions, particularly when accompanied by endocrinological signs, can easily prompt an erroneous diagnosis of pituitary adenoma. Hyperprolactinemia and hypopituitarism commonly result from compression of the pituitary stalk ("stalk section effect") and of the pituitary. 12, 14, 22, 23, 38 As a result, sellar chordomas may mimic prolactinomas or nonfunctioning pituitary adenomas.
Some authors advocate obtaining a preliminary transsphenoidal biopsy sample to establish a histological diagnosis that aids in the design of surgical therapy. 7, 11 Dynamic MR imaging may also contribute to the differentiation of sellar chordoma from meningioma, schwannoma, and metastatic tumor. 21 Magnetic resonance spectroscopy may provide additional information for the preoperative diagnosis of brain tumors. Based on differences in their metabolic profile, MR spectroscopy may differentiate pituitary adenomas from other sellar-region masses that originate outside the pituitary gland. With regard to sellar chordomas, however, it is of note that the technique failed to diagnose one recently reported chondroid chordoma involving the sellar region and left jugular foramen. 24 In addition to pituitary adenoma, 22 craniopharyngioma, 23 and a small number of rare tumors affecting the sellar region, 42 the differential diagnosis of chordoma also includes cartilaginous tumors of the skull base. 34 These include primarily chondrosarcoma and cartilage-containing chordomas ("chondroid chordoma"). The latter, long considered a special prognostically favorable variant of chordoma, 17 was the subject of a recent clinicopathological study, 34 in which the authors found no inherent difference in the survival of patients with such chordomas compared with conventional chordoma and chondrosarcoma. Instead, the more favorable prognosis in patients with chondroid chordoma was attributed to the tumors' occurrence in younger patients.
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Evident in the immunoprofile of chordoma cells is reactivity for LMW cytokeratins 7, 8, 18 , and 19 (simple epithelia), as well as HMW 4, 5, and 6 (mucosal epithelia), 18, 34, 40 vimentin, and EMA. 1, 5, 8, 32, 33 The results of our immunocytochemical analyses are in accordance with these findings. In both Cases 1 and 2, EMA and vimentin were expressed. Examination demonstrated immunoposi- tivity for a panepithelial cytokeratin cocktail in Case 1 and positivity for both LMW and HMW cytokeratins in Case 2. Approximately 50% of chordomas are S-100-protein immunoreactive. 34 Inconsistent staining results for CEA have also been reported. 5, 32, 33, 41 Immunostaining for NSE and ␣1-FP yields positive results in the majority of tumors. 1, 5, 8, 32, 34 Focal immunopositivity for S-100 and CEA was apparent in our two cases tested (Cases 1 and 2) . In addition to immunocytochemistry, electron microscopy has significantly contributed to the characterization of chordomas. 6, 20, 34 Although total removal of chordomas is the theoretical goal, as in cases of extraosseous chordoma, 31 this is only infrequently achieved. Adjuvant radiotherapy has been recommended to prolong disease-free survival, but its effect on prolonging overall survival has not been established. 15 Transsphenoidal surgery followed by radiotherapy is the generally accepted treatment. 2, 15, 17, 39 The development of a postirradiation sarcoma is a rare but serious complication 20 that should be distinguished from sarcomatous transformation of chordoma. 49 In terms of the surgery, the goal of initial management of sellar chordomas is a gross-total resection. 26, 29 Because of the distinct tendency of chordomas to invade surrounding bone, total removal is generally not possible. Specifically when extensive skull base procedures and large scale resections are performed, minute residua that have permeated bone are often left behind at the resection margins. In addition, chordomas also have the ability to invade and perforate nearby dura. A variety of strategies has been developed to achieve maximum tumor removal, including bifrontal, transsphenoidal, transpalatal, and transmandibular approaches. 27, 30 In most cases, a transsphenoidal approach permits very satisfactory resection of chordomas primarily involving the sella, and it offers the surgeon an opportunity to decompress the suprasellar compartment and optic chiasm, as well as cavernous sinus in which nerves subserving ocular movement may be affected. The transsphenoidal approach also permits one to treat midline tumor involvement of the clivus and of the clival dura. However, the surgeon should consider the limitations of the transsphenoidal approach, particularly when manipulating very hard tumors.
Because the majority of chordoma resections are by nature incomplete, adjunctive therapy is usually recommended. In our review of pediatric chordomas, it was interesting to note that all long-term survivors had undergone radiotherapy. 52 Conventional fractionated radiotherapy has been the most commonly used; however, stereotactically delivered radiosurgey, either linear accelerator or gamma knife, has recently come into vogue. 3, 13, 25, 35 In the future, these modalities may play a significant role in the treatment of chordomas; at present, it is too early to assess their efficacy. The Harvard group, which administered fractionated stereotactic proton-beam radiosurgery, has treated a large number of patients harboring chordomas and chondrochordomas of the skull base, 28 and their results have been outstanding. Their technique clearly permits the delivery of an effective radiation dose while protecting vital structures. Once a chordoma has been successfully resected, one ordinarily recommends annual follow up in which the patient undergoes high-quality imaging studies to assess for tumor recurrence.
The malignant behavior of skull base chordomas is primarily a function of their location, tendency to osseous permeation, and high rate of recurrence, rather than to their capacity for metastasis. 17, 38 The metastatic potential of chordomas cannot be estimated by histological examination, except in cases in which the lesion exhibits a highgrade, spindle-cell sarcomatous component. 19, 49 In recent clinicopathological studies the authors have claimed that longer survival times are demonstrated in patients younger than 40 years of age 15, 34 as well as in those presenting with diplopia. 15 The overall survival rate in the study of Forsyth, et al., 15 was estimated to be 51% and 35% at 10 and 20 years, respectively. With regard to DNA analysis of chordomas, recent findings have shown a statistical trend in the relationship of diploidy and a favorable prognosis. 44, 45 The long recurrence-free period observed in one patient (Case 19, Table 1 ) in our series may be related to the diploid DNA histogram of the tumor.
In summary, sellar chordomas are rare. Their occasionally favorable prognosis no doubt relates to the limited extent of the disease and the aggressiveness of the surgical resection. The effect of radiation therapy on disease-free and overall survival remains unsettled.
